CHL1 and neoplasm: The final tumor volume in mice treated with siRNA targeting CHL1 was lower than that in mice treated with control siRNA, although no statistical significance was detected (1689.41 ± 239.46 vs. 1877.50 ± 325.11 mm3, p = 0.2768 vs. control siRNA, Figure 9D).